Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Scand J Infect Dis ; 33(8): 625-7, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11525360

RESUMO

A previously healthy 6-y-old girl presented with a disease very similar to pneumococcal pneumonia. However, Moraxella osloensis was isolated by lung tap. The patient responded well to a course of parenteral penicillin. This is probably the first documented case of community-acquired pneumonia associated with this agent. Clinical isolates of M. osloensis are rare and its pathogenesis has not been delineated; however, a literature review suggests that the organism is more common than is generally recognized.


Assuntos
Moraxella/isolamento & purificação , Infecções por Neisseriaceae/diagnóstico , Pneumonia Bacteriana/diagnóstico , Criança , Diagnóstico Diferencial , Feminino , Humanos , Infecções por Neisseriaceae/microbiologia , Pneumonia Bacteriana/microbiologia , Pneumonia Pneumocócica/diagnóstico , Resultado do Tratamento
2.
Int J Infect Dis ; 5(1): 3-8, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11285152

RESUMO

OBJECTIVES: To explore whether 4-day parenteral beta-lactam therapy is as effective as 7-day therapy for children hospitalized for parenteral antimicrobials. METHODS: A series of patients aged 3 months to 15 years who fulfilled strict criteria for bacterial pneumonia, other respiratory infections, sepsis-like infections, and other acute infections were prospectively randomized to receive parenteral penicillin or cefuroxime randomly for 4 or 7 days. Besides blood and throat cultures, the etiology was searched by serology for 23 different agents. RESULTS: Of 154 children analyzed, a probable etiology was established in 96. Of those, a bacterial infection, with or without concomitant viral infection, was disclosed in 80% and 94% in the 4-day and 7-day treatment groups, respectively; pneumococcus being the commonest agent. There was one possible treatment failure in the 4-day group, but with a questionable relation to the short course. Three patients in the 4-day and two in the 7-day group underwent treatment changes, or were rehospitalized within 30 days. All children recovered entirely. CONCLUSIONS: Shortening parenteral beta-lactam treatment to 4 days in infections for which most parenteral antimicrobials are instituted, is not only safe, but reduces costs, is ecologically sound, and minimizes the risks of nosocomial infections and other adverse effects of treatment.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Cefuroxima/administração & dosagem , Cefuroxima/uso terapêutico , Penicilinas/administração & dosagem , Penicilinas/uso terapêutico , Adolescente , Infecções Bacterianas/microbiologia , Cefuroxima/efeitos adversos , Cefuroxima/farmacologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Penicilinas/efeitos adversos , Penicilinas/farmacologia , Infecções Pneumocócicas/tratamento farmacológico , Infecções Pneumocócicas/microbiologia , Distribuição Aleatória , Sepse/tratamento farmacológico , Sepse/microbiologia , Testes Sorológicos , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificação , Fatores de Tempo , Resultado do Tratamento
3.
Clin Infect Dis ; 32(5): 715-26, 2001 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-11229839

RESUMO

Identification of the etiology of childhood pneumonia is difficult, even in the cases that most likely have bacterial origins. A positive blood culture result is diagnostic but rare (< 10% of cases), and other noninvasive microbiological methods are nonspecific or are at least shadowed by interpretation problems. However, lung tap (or aspiration), a method developed a century ago, warrants reappraisal, especially since the prevalence of pneumococcal resistance to penicillin is increasing. An analysis of 59 studies that were published in 6 languages led us to conclude that (1) bacterial etiology is disclosed in approximately 50% of cases (virological tests were rarely done); (2) lung tap is safer than is generally considered; (3) potential pneumothorax is mostly symptomless and resolves spontaneously without impairing recovery; and (4) in comparison with routine diagnostic tools, lung tap offers so many advantages that it warrants reconsideration at centers where personnel have experience in handling potential pneumothorax.


Assuntos
Biópsia por Agulha , Pneumonia Bacteriana/diagnóstico , Pneumonia Viral/diagnóstico , Adolescente , Biópsia por Agulha/efeitos adversos , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Pulmão/microbiologia , Pulmão/patologia , Pulmão/virologia , Pneumonia Bacteriana/microbiologia , Pneumonia Viral/virologia
4.
Pediatr Infect Dis J ; 20(1): 52-8, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11176567

RESUMO

BACKGROUND: Little is known of the etiology of childhood acute lower respiratory infections in China, where the use of antimicrobials is indiscriminate. Trials to change such a policy require etiologic data, especially on the bacteria most relevant to these common diseases. METHODS: One hundred consecutive infants and children from 3 months to 14 years of age with symptoms and signs compatible with acute lower respiratory infections were studied prospectively in the largest pediatric hospital in Beijing from February to May, 1997. Blood culture, thorax radiography and paired sera for 20 microbiologic assays were taken, and the course of illness was monitored uniformly. Disease severity was graded. RESULTS: In 24 cases there was evidence only of bacterial etiology, and in 5 solely viral agents were found; 3 children probably had a mixed bacterial-viral infection. Surprisingly no pneumococcal infection was detected, Mycoplasma pneumoniae (n = 21), Haemophilus influenzae type b (n = 8) and Chlamydia pneumoniae (n = 7) being the dominant bacteria. All children recovered. CONCLUSIONS: Routine use of antimicrobials for these patients seems unjustified. Serologic evidence for the H. influenzae type b etiology is encouraging in terms of vaccination, but confirmatory studies are needed.


Assuntos
Infecções Respiratórias/etiologia , Adolescente , Antibacterianos/uso terapêutico , Anticorpos Antibacterianos/sangue , Anticorpos Antivirais/sangue , Infecções Bacterianas/epidemiologia , Infecções Bacterianas/etiologia , Infecções Bacterianas/microbiologia , Criança , Pré-Escolar , China/epidemiologia , Testes de Fixação de Complemento , Contraindicações , Feminino , Humanos , Técnicas Imunoenzimáticas , Lactente , Masculino , Estudos Prospectivos , Radiografia Torácica , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/microbiologia , Viroses/epidemiologia , Viroses/etiologia , Viroses/virologia
5.
Eur J Pediatr ; 159(12): 878-84, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11131342

RESUMO

UNLABELLED: Overuse of broad-spectrum antimicrobials has resulted in increasing bacterial resistance in many countries. We hypothesised that common childhood infections requiring parenteral medication are still curable with narrow-spectrum and inexpensive penicillin. A prospective and randomised study was performed in two referral hospitals in Helsinki. A total of 154 children aged 3 months to 15 years with pneumonia or other lower respiratory infections, sepsis-like infections, or other common acute infections warranting hospitalisation and parenteral antimicrobials were included. At random, 50% of children received procaine penicillin intramuscularly, the other 50% cefuroxime intravenously for 4-7 days. The course of illness was monitored with predetermined laboratory and radiological indices, by filling in a special form daily and a follow-up for 30 days after discharge. The infectious agent was searched for with a large laboratory set-up covering 23 bacterial, viral or protozoan species. The two groups were very similar at presentation. Probable aetiology was disclosed in 56% of the penicillin and in 68% of the cefuroxime recipients, the leading agent in both groups being Pneumococcus. In 8% only a viral aetiology was found. The children recovered with the same speed, regardless of which antimicrobial used, there being one possible failure in each group but no difference in the frequency of needing a physician again within 1 month of discharge. No adverse event was attributable to either drug. CONCLUSION: Procaine penicillin is as effective and safe as cefuroxime for common community-acquired infections in immunocompetent children.


Assuntos
Cefuroxima/uso terapêutico , Cefalosporinas/uso terapêutico , Doenças Transmissíveis/tratamento farmacológico , Penicilina G Procaína/uso terapêutico , Penicilinas/uso terapêutico , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...